DXCM
DXCM clinical trials: DEXCOM INC
Every trial on ClinicalTrials.gov where DEXCOM INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 170
- Trials linked
- 35
- As lead sponsor
- 135
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
DXCM on the catalyst calendar · DXCM registry changes
- Primary completion Mar 31, 2028Sponsor estimateNo phase registeredNCT06483945Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)DexCom, Inc. · DiabetesActive, not recruitingDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 13, 2026ActualNo phase registeredNCT06601166CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on InsulinDexCom, Inc. · Type 2 DiabetesActive, not recruitingDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 16, 2026ActualPhase 1NCT07681375Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 SensorDexCom, Inc. · Type 2 DiabetesActive, not recruitingDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 1, 2030Sponsor estimateNo phase registeredNCT07681024Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW)DexCom, Inc. · DiabetesNot yet recruitingDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2, 2026Sponsor estimatePhase 4NCT07603284Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi ArabiaDexCom, Inc. · Type 2 Diabetes on InsulinActive, not recruitingDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 29, 2023ActualNo phase registeredNCT05746286Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for DysglycemiaDexCom, Inc. · DysglycemiaCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 22, 2019ActualNo phase registeredNCT04529824Glucose Risk Assessment in Employer PopulationsDexCom, Inc. · DiabetesCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 7, 2022ActualNo phase registeredNCT04585139Assessing Non-adjunctive CGM Safety at Home and in New MarketsDexCom, Inc. · Diabetes MellitusCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2022Sponsor estimateNo phase registeredNCT04905628Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes MellitusDexCom, Inc. · Diabetes MellitusUnknown statusDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 9, 2021ActualNo phase registeredNCT04794478Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) SystemDexCom, Inc. · Diabetes MellitusCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 27, 2022Sponsor estimateNo phase registeredNCT04503239Prediabetes and Type 2 Diabetes Data Collection StudyDexCom, Inc. · Diabetes Mellitus, Type 2Unknown statusDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 30, 2023Sponsor estimateNo phase registeredNCT03340831Continuous Monitoring and Control of HypoglycemiaDexCom, Inc. · DiabetesUnknown statusDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2021Sponsor estimateNo phase registeredNCT04879693Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient SettingDexCom, Inc. · Patients Needing Glucose ControlUnknown statusDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 4, 2021ActualNo phase registeredNCT03566693Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)DexCom, Inc. · Diabetes Mellitus, Type 2CompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 16, 2021ActualNo phase registeredNCT04840446Evaluation of Modified Adhesives With Dexcom G6 SensorDexCom, Inc. · DiabetesCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 27, 2020ActualNo phase registeredNCT03620357Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)DexCom, Inc. · Diabetes Mellitus, Type 2CompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2020Sponsor estimateNo phase registeredNCT04645641Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) SystemDexCom, Inc. · Diabetes MellitusUnknown statusDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2019Sponsor estimateNo phase registeredNCT03935191Performance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes MellitusDexCom, Inc. · DiabetesUnknown statusDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 4, 2017ActualNo phase registeredNCT03087877Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent SensorDexCom, Inc. · Diabetes MellitusCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2017ActualNo phase registeredNCT02880267Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring SystemDexCom, Inc. · Diabetes MellitusCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2012ActualNo phase registeredNCT02363907Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in PediatricsDexCom, Inc. · Diabetes MellitusCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2014ActualNo phase registeredNCT02087995Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified AlgorithmDexCom, Inc. · Diabetes MellitusCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2016ActualNo phase registeredNCT02282397Multiple Daily Injections and Continuous Glucose Monitoring in DiabetesDexCom, Inc. · Diabetes MellitusCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2010ActualNo phase registeredNCT01111370Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring SystemDexCom, Inc. · Diabetes MellitusCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2016ActualNo phase registeredNCT02696252G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor ApplicatorDexCom, Inc. · Diabetes MellitusCompletedDXCMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 145 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner